26B-4-245. Purchasing and use limitations.
270 words·~1 min read·
/ut/title-26b/chapter-4/26b-4-245A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Effective 5/6/2026
26B-4-245. Purchasing and use limitations.
(1)An individual with a medical cannabis card:
(a)may purchase, in any one 28-day period, up to the legal dosage limit of:
(i)unprocessed cannabis in a medicinal dosage form; and
(ii)a cannabis product in a medicinal dosage form;
(b)may not purchase:
(i)except as provided in Subsection
(2), more medical cannabis than described in Subsection (1)(a) ; or
(ii)if the relevant recommending medical provider did not recommend directions of use and dosing guidelines, until the individual consults with the pharmacy medical provider in accordance with Subsection 26B-4-231(5) , any medical cannabis; and
(c)may not use a route of administration that the relevant recommending medical provider or the pharmacy medical provider, in accordance with Subsection 26B-4-231(5) , has not recommended.
(a)A recommending medical provider may petition the department to waive the 28-day period limit described in Subsection (1)(a) for a medical cannabis cardholder if the medical cannabis cardholder:
(i)has been diagnosed with a terminal illness;
(ii)has a life expectancy of six months or less; and
(iii)needs the waiver for palliative purposes.
(b)The department shall:
(i)consult with the Compassionate Use Board to determine whether the waiver should be granted; and
(ii)issue a response to the petition within 10 days from the day on which the petition is received.
(c)The department may waive the 28-day period limit for no more than 180 days.
(d)A petition described in this Subsection
(2)may be combined with the petition described in Subsection 4-41a-112(5) .
Amended by Chapter 421 , 2026 General Session